Correlation Between Willamette Valley and Neumora Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Willamette Valley and Neumora Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Willamette Valley and Neumora Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Willamette Valley Vineyards and Neumora Therapeutics, Common, you can compare the effects of market volatilities on Willamette Valley and Neumora Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Willamette Valley with a short position of Neumora Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Willamette Valley and Neumora Therapeutics,.

Diversification Opportunities for Willamette Valley and Neumora Therapeutics,

0.26

Correlation Coefficient

Willamette Valley  Neumora Therapeutics,

Modest diversification

The 3 months correlation between Willamette and Neumora is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Willamette Valley Vineyards and Neumora Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neumora Therapeutics, and Willamette Valley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Willamette Valley Vineyards are associated (or correlated) with Neumora Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neumora Therapeutics, has no effect on the direction of Willamette Valley i.e., Willamette Valley and Neumora Therapeutics, go up and down completely randomly.

Pair Corralation between Willamette Valley and Neumora Therapeutics,

Assuming the 90 days horizon Willamette Valley Vineyards is expected to generate 0.43 times more return on investment than Neumora Therapeutics,. However, Willamette Valley Vineyards is 2.35 times less risky than Neumora Therapeutics,. It trades about -0.01 of its potential returns per unit of risk. Neumora Therapeutics, Common is currently generating about -0.03 per unit of risk. If you would invest  471.00  in Willamette Valley Vineyards on October 10, 2024 and sell it today you would lose (127.00) from holding Willamette Valley Vineyards or give up 26.96% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	67.0%
Values	Daily Returns

Willamette Valley Vineyards  vs.  Neumora Therapeutics, Common

Willamette Valley

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Willamette Valley Vineyards has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, Willamette Valley is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Neumora Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neumora Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Willamette Valley and Neumora Therapeutics,

The main advantage of trading using opposite Willamette Valley and Neumora Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Willamette Valley position performs unexpectedly, Neumora Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neumora Therapeutics, will offset losses from the drop in Neumora Therapeutics,'s long position.

The idea behind Willamette Valley Vineyards and Neumora Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.